Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/119666

In Collections

This item can be found in the following collections:

Kater, A.P.; Oers, M.H.J. van; Norden, Y. van; Straten, L. van der; Driessen, J.; Posthuma, W.F.M.; ... ; HOVON CLL Study Grp (2019)

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Article / Letter to editor
All authors
Kater, A.P.; Oers, M.H.J. van; Norden, Y. van; Straten, L. van der; Driessen, J.; Posthuma, W.F.M.; Schipperus, M.; Chamuleau, M.E.D.; Nijland, M.; Doorduijn, J.K.; Gelder, M. van; Hoogendoorn, M.; Croon, F. de; Wittebol, S.; Kerst, J.M.; Marijt, E.W.A.; Raymakers, R.A.P.; Schaafsma, M.R.; Dobber, J.A.; Kersting, S.; Levin, M.D.; HOVON CLL Study Grp
Date
2019-01-31
Journal
Haematologica
Volume
104
Issue
1
Pages
147 - 154
DOI
doi:10.3324/haematol.2018.193854